Key Takeaways WST reported Q4 adjusted EPS of $2.04, up 12.1%, beating estimates by 11.5%.Q4 revenues rose 7.5% to $805M, driven by Proprietary and Contract segments.WST guides 2026 revenues of $3.21B-$3.27B and EPS of $7.82-$8.20, above consensus.West Pharmaceutical Services, Inc. (WST) delivered adjusted fourth-quarter 2025 earnings per share (EPS) of $2.04, which moved up 12.1% year over year. The figure topped the Zacks Consensus Estimate by 11.5%.The adjustments include expenses related to the amortiza ...